Prognostic Value of T-Wave Alternans in Patients With Heart Failure Due to Nonischemic Cardiomyopathy. Results of the ALPHA Study

Journal of the American College of Cardiology

Volumn 50, Issue 19, 2007, Pages 1896-1904

  Salerno Uriarte, Jorge A ^a   De Ferrari, Gaetano M ^b   Klersy, Catherine ^b   Pedretti, Roberto F E ^c   Tritto, Massimo ^d   Sallusti, Luciano ^e   Libero, Luigi ^f   Pettinati, Giacinto ^g   Molon, Giulio ^h   Curnis, Antonio ⁱ   Occhetta, Eraldo ^j   Morandi, Fabrizio ^a   Ferrero, Paolo ^f   Accardi, Francesco ^e  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c IRCCS   (Italy)

^d Istituto Clinico Mater Domini   (Italy)

^e Dipartimento Clinico   (Italy)

^f UNIVERSITY OF TURIN   (Italy)

^g Divisione di Cardiologia   (Italy)

^h SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

ⁱ UNIVERSITY OF BRESCIA   (Italy)

^j UNIVERSITY OF EASTERN PIEDMONT   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOMYOPATHY; CONFIDENCE INTERVAL; DEFIBRILLATOR; DISEASE CLASSIFICATION; FEMALE; FUNCTIONAL ASSESSMENT; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; RISK ASSESSMENT; T WAVE;

AGED; ARRHYTHMIAS, CARDIAC; CARDIAC OUTPUT, LOW; CARDIOMYOPATHY, DILATED; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; STROKE VOLUME; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 35548997299     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.09.004     Document Type: Article

References (40)

1. Zipes D.P., and Wellens H.J.J. Sudden cardiac death. Circulation 98 (1998) 2334-2351
2. Bardy G.H., Lee K.L., Mark D.B., et al., Sudden Cardiac Death in Heart Failure Trial (SCD-HEFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
3. Buxton A.E., and Moss A.J. Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter defibrillator?. Circulation 111 (2005) 2537-2549
4. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). Circulation 114 (2006) 1088-1132
5. Centers for Medicare and Medicaid Services. Decision memo for implantable defibrillators (CAG-00157R3). Available at: http://www.cms.hhs.gov/mcd/viewdecisionmemo.asp?id=148. Accessed November 16, 2006.
6. Bloomfield D.M., Steinman R.C., Namerow P.B., et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy. A solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation 110 (2004) 1885-1889
7. Klingenheben T., Zabel M., D'Agostino R.B., Cohen R.J., and Hohnloser S.H. Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure. Lancet 356 (2000) 651-652
8. Sarzi Braga S., Vaninetti R., Laporta A., Picozzi A., and Pedretti R.F.E. T-wave alternans is a predictor of death in patients with congestive heart failure. Int J Cardiol 93 (2004) 31-38
9. Kitamura H., Ohnishi Y., Okajima K., et al. Onset heart rate of microvolt-level T-wave alternans provides clinical and prognostic value in nonischemic dilated cardiomyopathy. J Am Coll Cardiol 39 (2002) 295-300
10. Hohnloser S.H., Klingenheben T., Bloomfield D., Dabbous O., and Cohen R.J. Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study. J Am Coll Cardiol 41 (2003) 2220-2224
11. Grimm W., Christ M., Bach J., Müller H.H., and Maisch B. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy. Results of the Marburg Cardiomyopathy Study. Circulation 108 (2003) 2883-2891
12. Baravelli M., Salerno-Uriarte D., Guzzetti D., et al. Predictive significance for sudden death of microvolt-level T wave alternans in New York Heart Association class II congestive heart failure patients: a prospective study. Int J Cardiol 105 (2005) 53-57
13. Narayan S.M. T-wave alternans and the susceptibility to ventricular arrhythmias. J Am Coll Cardiol 47 (2006) 269-281
14. Strickberger S.A., Hummel J.D., Bartlett T.G., et al., AMIOVIRT Investigators. Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia. J Am Coll Cardiol 41 (2003) 1707-1712
15. Grimm W., Glaveris C., Hoffmann J., et al. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: design and first results of the Marburg Cardiomyopathy Study. Pacing Clin Electrophysiol 21 (1998) 2551-2556
16. Salerno-Uriarte J.A., Pedretti R.F.E., Tritto M., De Ferrari G.M., Klersy C., and Sallusti L. The ALPHA study (T-Wave Alternans in Patients With Heart Failure): rationale, design and end-points. Ital Heart J 5 (2004) 587-592
17. De Ferrari G.M., Klersy C., Ferrero P., et al., ALPHA Study Group. Atrial fibrillation in heart failure patients: prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry. Eur J Heart Fail 9 (2007) 502-509
18. Rosenbaum D.S., Jackson L.E., Smith J.M., Garan H., Ruskin J.N., and Cohen R.J. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 330 (1994) 235-241
19. Bloomfield D.M., Hohnloser S.H., and Cohen R.J. Interpretation and classification of microvolt T wave alternans tests. J Cardiovasc Electrophysiol 13 (2002) 502-512
20. Hohnloser S.H., Ikeda T., Bloomfield D.M., Dabbous O.H., and Cohen R.J. T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation. Lancet 362 (2003) 125-126
21. Kaufman E.S., Bloomfield D.M., Steinman R.C., et al. "Indeterminate" microvolt T-wave alternans tests predict high risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 48 (2006) 1399-1404
22. Bloomfield D.M., Bigger J.T., Steinman R.C., et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 47 (2006) 456-463
23. Chow T., Kereiakes D.J., Bartone C., et al. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. J Am Coll Cardiol 47 (2006) 1820-1827
24. Hinkle Jr. L.E., and Thaler H.T. Clinical classification of cardiac deaths. Circulation 65 (1982) 457-464
25. Buxton A.E., Lee K.L., DiCarlo L., et al., Multicenter Unsustained Tachycardia Trial Investigators. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. N Engl J Med 342 (2000) 1937-1945
26. Schemper M., and Smith T.L. A note on quantifying follow-up in studies of failure time. Contr Clin Trials 17 (1996) 343-346
27. Schoenfeld D. Partial residuals for the proportional hazard regression model. Biometrika 69 (1982) 239-241
28. Bardy G.H., Lee K.L., Mark D.B., et al., Sudden Cardiac Death in Heart Failure Trial (SCD-HEFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. New Engl J Med 352 (2005) 225-237
29. Gehi A.K., Stein R.H., Metz L.D., and Gomes J.A. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events. A meta-analysis. J Am Coll Cardiol 46 (2005) 75-82
30. Tomaselli G.F., and Zipes D.P. What causes sudden death in heart failure?. Circ Res 95 (2004) 754-763
31. De Ferrari G.M., and Tavazzi L. The role of arrhythmias in the progression of heart failure. Eur J Heart Fail 1 (1999) 35-40
32. Gomes J.A., Winters S.L., and Ip J. Post myocardial infarction stratification and the signal-averaged electrocardiogram. Prog Cardiovasc Dis 35 (1993) 263-270
33. Pedretti R., Etro M.D., Laporta A., Sarzi Braga S., and Carù B. Prediction of late arrhythmic events after acute myocardial infarction from combined use of noninvasive prognostic variables and inducibility of sustained monomorphic ventricular tachicardia. Am J Cardiol 71 (1993) 1131-1141
34. De Ferrari G.M., Rordorf R., Frattini F., Petracci B., De Filippo P., and Landolina M. Predictive value of programmed ventricular stimulation in patients with ischemic cardiomyopathy: implications for the selection of candidates for an implantable defibrillator. Europace (2007) In press
35. Turitto G., Ahuja R.K., Caref E.B., and el-Sherif N. Risk stratification for arrhythmic events in patients with nonischemic dilated cardiomyopathy and nonsustained ventricular tachycardia: role of programmed ventricular stimulation and the signal-averaged electrocardiogram. J Am Coll Cardiol 24 (1994) 1523-1528
36. Rosenqvist M., Beyer T., Block M., den Dulk K., Minten J., Lindemans F., and European 7219 Jewel ICD Investigators. Adverse events with transvenous implantable cardioverter-defibrillators: a prospective multicenter study. Circulation 98 (1998) 663-670
37. Kron J., Herre J., Renfroe E.G., et al., AVID Investigators. Lead- and device-related complications in the Antiarrhythmics Versus Implantable Defibrillators trial. Am Heart J 141 (2001) 92-98
38. Schron E.B., Exner D.V., Yao Q., et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 105 (2002) 589-594
39. Irvine J., Dorian P., Baker B., et al. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J 144 (2002) 282-289
40. Kadish A., Dyer A., Daubert J.P., et al., Defibrillators in Non-ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350 (2004) 2151-2158